[{"NetIncomeLoss_3_Q3_USD":-205451000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":17000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-289000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":1791000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":28946000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_1_Q3_USD":1203000.0,"OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent_3_Q3_USD":649000.0,"AssetsCurrent_0_Q3_USD":585277000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":9197000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":25361000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":6554000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q3_USD":4576000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermDebt_3_Q3_USD":155249000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":259161799.0,"InterestPaidNet_3_Q3_USD":16712000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":258091170.0,"LongTermDebt_0_Q3_USD":388584000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":112722000.0,"InventoryWorkInProcessNetOfReserves_0_Q3_USD":8201000.0,"CommonStockSharesIssued_0_Q3_shares":259600650.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":272679000.0,"InterestExpenseDebtExcludingAmortization_1_Q3_USD":6250000.0,"InterestExpenseDebtExcludingAmortization_3_Q3_USD":13245000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":15908000.0,"OtherNoncashIncomeExpense_3_Q3_USD":0.0,"StockIssuedDuringPeriodValueShareBasedCompensation_3_Q3_USD":36912000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":9295000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":20028000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":26878000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":8399000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":21627000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":37850000.0,"InventoryValuationReserves_0_Q3_USD":100000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":298451000.0,"MarketableSecuritiesCurrent_0_Q3_USD":298451000.0,"Liabilities_0_Q3_USD":580273000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_3_Q3_USD":-9340000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":-23424000.0,"WarrantsAndRightsOutstanding_0_Q3_USD":12387000.0,"CommonStockValue_0_Q3_USD":2626000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":727000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":4791000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q3_USD":-1243000.0,"AccountsReceivableNetCurrent_0_Q3_USD":44828000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":29000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":-7276000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-7276000.0,"AssetsFairValueDisclosure_0_Q3_USD":301957000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":58000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-344000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":3019000.0,"DeferredCreditsAndOtherLiabilitiesNoncurrent_0_Q3_USD":8906000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":6299000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3_Q3_USD":-2680000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":2274797000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":44627000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":210631000.0,"OtherAssetsNoncurrent_0_Q3_USD":26453000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-64644000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-203756000.0,"DepreciationDepletionAndAmortization_1_Q3_USD":2496000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":89595000.0,"DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_0_Q3_USD":3585000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":2680000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":241310000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":70419000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":229150000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_1_Q3_USD":-1034000.0,"IncreaseDecreaseInInventories_3_Q3_USD":-2182000.0,"Assets_0_Q3_USD":900542000.0,"ShareBasedCompensation_3_Q3_USD":36912000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":23397000.0,"AccountsPayableCurrent_0_Q3_USD":14764000.0,"LiabilitiesCurrent_0_Q3_USD":111727000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":8800000.0,"ProceedsFromWarrantExercises_3_Q3_USD":0.0,"InventoryRawMaterialsNetOfReserves_0_Q3_USD":1012000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-183468000.0,"InterestExpense_3_Q3_USD":14148000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_1_Q3_USD":-91000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-63284000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-200660000.0,"Goodwill_0_Q3_USD":197797000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":159000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-633000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":1695000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_3_Q3_USD":-25000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":23582000.0,"InterestExpense_1_Q3_USD":6784000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":15600000.0,"NetIncomeLoss_1_Q3_USD":-64011000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":44618000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":16561000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":265000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":5051000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":117700000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":213425000.0,"ProceedsFromDebtNetOfIssuanceCosts_3_Q3_USD":385929000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q3_USD":-56000.0,"GrossProfit_1_Q3_USD":59038000.0,"GrossProfit_3_Q3_USD":168688000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":23000000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":210631000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":20028000.0,"DebtSecuritiesRealizedGainLoss_3_Q3_USD":0.0,"PaymentsToAcquireMarketableSecurities_3_Q3_USD":261322000.0,"CommonStockSharesOutstanding_0_Q3_shares":259600650.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":10845000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":15908000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":36912000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":900542000.0,"InvestmentIncomeInterest_1_Q3_USD":518000.0,"InvestmentIncomeInterest_3_Q3_USD":2898000.0,"FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0_Q3_USD":25361000.0,"AmortizationOfDebtDiscountPremium_3_Q3_USD":869000.0,"InventoryNet_0_Q3_USD":15767000.0,"OperatingIncomeLoss_1_Q3_USD":-52761000.0,"OperatingIncomeLoss_3_Q3_USD":-182163000.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-4377000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":0.0,"AllowanceForDoubtfulAccountsReceivable_0_Q3_USD":100000.0,"AmortizationOfDebtDiscountPremium_1_Q3_USD":395000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":7368000.0,"OperatingExpenses_3_Q3_USD":350851000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":67084000.0,"PaymentsForTenantImprovements_3_Q3_USD":470000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1974061000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":1124000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":67437000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":190315000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":2794000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":298309000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2160000.0,"StockholdersEquity_0_Q3_USD":320269000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":4817000.0,"ProfitLoss_3_Q3_USD":-205451000.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.25,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.8,"OperatingExpenses_1_Q3_USD":111799000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":-96000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":45000.0,"Ticker":"FOLD","CIK":"1178879","name":"AMICUS THERAPEUTICS, INC.","OfficialName":"Amicus Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"2296240629.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]